DAPING 10 Tablet

What is DAPING 10 Tablet?

DAPING 10 Tablet contains dapagliflozin 10 mg, an SGLT2 inhibitor used in adults to manage type 2 diabetes and to reduce cardiorenal risks in selected patients. It lowers blood sugar by helping the kidneys remove excess glucose through urine and also provides proven benefits in heart failure and chronic kidney disease in appropriate patients.​

Key Benefits

• Helps improve glycaemic control in adults with type 2 diabetes when used with diet and exercise, alone or with other antidiabetic drugs.​

• Reduces risk of hospitalisation for heart failure and slows kidney disease progression in eligible patients with cardiovascular or renal risk.​

Uses & Indications

Doctors prescribe DAPING 10 Tablet (dapagliflozin 10 mg) for:​

• Type 2 diabetes mellitus to lower blood glucose, as monotherapy or in combination with metformin, insulin or other agents.​

• Heart failure and chronic kidney disease indications where dapagliflozin 10 mg is recommended to reduce hospitalisation, CV death or renal decline, in line with guidelines.​

It is not indicated for type 1 diabetes or for treatment of diabetic ketoacidosis.​

Dosage & Directions

The exact regimen must be decided by the treating physician.​

• Usual adult dose: dapagliflozin 10 mg once daily, taken with or without food, at the same time each day.​

• Swallow the tablet whole with water; continue diet, exercise and other diabetes medicines as advised.​

Dose adjustments or discontinuation may be needed in acute illness, surgery, dehydration or declining kidney function.​

Price & Packaging

DAPING 10 Tablet is marketed in strips, typically of 10 film‑coated tablets.​

• Trade and pharmacy listings show MRPs in the range of ₹140–₹200 per strip, with patient prices depending on retailer and discounts.​

• Packs are supplied in cartons suitable for clinics and pharmacies, with composition, batch number and expiry clearly printed.​

Always check the MRP, batch number, manufacturing date and expiry date before dispensing or use.​

Side Effects & Safety

Common side effects of dapagliflozin include:​

• Increased urination, urinary tract infections, genital yeast infections, thirst, dizziness or dehydration.​

• Nasopharyngitis (sore throat, runny nose), back pain or mild gastrointestinal symptoms.​

Serious but less common risks include ketoacidosis (even with near‑normal glucose), severe urinary infections, Fournier’s gangrene and marked volume depletion or hypotension. Any symptoms such as abdominal pain, vomiting, rapid breathing, confusion, high fever, severe pain in the genital area, or very low blood pressure need urgent medical assessment.​

Precautions & Contraindications

• Not recommended in type 1 diabetes or for treating diabetic ketoacidosis due to increased DKA risk.​

• Use with caution in patients with eGFR < 25 mL/min; initiation may be avoided in severe renal impairment, and indications differ by kidney function.​

• Dehydration, hypotension, recurrent UTIs or genital infections, elderly patients and those on diuretics require careful monitoring.​

• Inform the doctor about history of ketoacidosis, pancreatic disease, very low‑carb diets, alcohol excess or use of insulin/secretagogues (hypoglycaemia risk).​

• Use in pregnancy and breastfeeding should follow a strict risk–benefit evaluation; often alternative agents are preferred.​

10 Frequently Asked Questions (FAQ)

1. What is DAPING 10 Tablet used for?
It is used to manage blood sugar in type 2 diabetes and, in suitable patients, to lower heart failure and kidney‑disease risks.​

2. How does dapagliflozin 10 mg work?
It blocks SGLT2 in the kidney, causing excess glucose to be excreted in urine, thereby lowering blood sugar and reducing some cardiorenal stresses.​

3. When should I take DAPING 10?
Take it once daily, at the same time each day, with or without food as your doctor advises.​

4. Can DAPING 10 cause low blood sugar?
On its own it rarely causes hypoglycaemia, but the risk increases when combined with insulin or sulfonylureas; dose adjustment of those agents may be needed.​

5. What about frequent urination?
Passing urine more often is expected; maintain good hydration and inform your doctor if you develop pain, burning or fever suggestive of infection.​

6. Does it help with weight or blood pressure?
Many patients experience modest weight loss and small blood‑pressure reductions due to glucose and fluid loss, but this varies and is not the sole goal of therapy.​

7. What should I do if I’m unwell or fasting?
During acute illness, surgery or prolonged fasting, your doctor may advise temporarily stopping dapagliflozin to reduce ketoacidosis risk.​

8. Can people with kidney problems take DAPING 10?
Some CKD patients benefit, but initiation or continuation depends on eGFR and indication; specialist guidance and regular monitoring are essential.​

9. What if I miss a dose?
Take the missed tablet when remembered the same day; if it is almost time for the next dose, skip it—never double the dose.​

10. When should I seek urgent medical care?
Seek help for signs of DKA (nausea, vomiting, abdominal pain, fast breathing, confusion), severe genital or urinary pain/infection, or symptoms of very low blood pressure.​

Quick Tips

• Stay well hydrated, especially during hot weather or when on diuretics, to reduce dehydration and dizziness.​

• Maintain good genital hygiene and report any itching, discharge or pain early to treat infections promptly.​

• Continue diet, exercise and scheduled lab checks (HbA1c, kidney function, lipids) as part of comprehensive diabetes care.​

Why Choose Ingram BioSciences?

DAPING 10 Tablet is part of Ingram BioSciences’ Cardio‑Diabetes Care portfolio, which includes products such as Gramoz‑GT500, MAXIHEME PLUS and others for chronic disease management. The company works with WHO‑GMP–aligned manufacturing partners and presents clear product information and disclaimers encouraging physician‑supervised use.​

This focused therapeutic presence supports trust in DAPING 10 Tablet as a dapagliflozin 10 mg option within Indian diabetes and cardiometabolic practice.​

Customer Support & Ordering

For information, distribution or business enquiries related to DAPING 10 Tablet:

• Manufacturer/Marketer: Ingram Biosciences Pvt Ltd.​

• Delhi Office Address: Unit 308, 3rd Floor, Living Style Mall, Jasola, New Delhi‑110025, India.​

• Phone / WhatsApp: +91 99997 81444; Mobile: +91 76690 11534.​

• Email: info@ingrambiosciences.in​

DAPING 10 Tablet is available via hospitals, retail pharmacies, franchise partners and major online platforms, and must be used only on the prescription and supervision of a registered medical practitioner.